CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Orexo Ab Company Snapshot
Orexo Ab operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orexo Ab with three other pharmaceutical manufacturers in Europe: Solon Eiendom ASA of Norway (2016 sales of 691.50 million Norwegian Kroner [US$81.71 million] ), Quantum Pharma PLC of the United Kingdom (£69.99 million [US$87.38 million] of which 85% was Specials), and Antibiotice SA which is based in Romania (333.07 million Romanian Leu [US$78.91 million] ).

Sales Analysis. During the year ended December of 2016, sales at Orexo Ab were SEK 705.90 million (US$80.23 million). This is an increase of 9.7% versus 2015, when the company's sales were SEK 643.34 million. This was the fifth consecutive year of sales increases at Orexo Ab (and since 2011, sales have increased a total of 254%). Sales of Zubsolv saw an increase of 15.6% in 2016, from SEK 416.70 million to SEK 481.80 million. Not all segments of Orexo Ab experienced an increase in sales in 2016: sales of Milestone Payment Abstral fell 96.7% to SEK 2.20 million. Orexo Ab also experienced decreases in sales in Royalty - Abstral (down 25.2% to SEK 100.40 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Orexo Ab
  Stock Performance Chart for Orexo Ab
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 29.10
(Figures in Swedish Kronor)
1 Week -4.3%   13 Weeks -7.0%  
4 Weeks -17.8%   52 Weeks -47.8%  
 
Orexo Ab Key Data:
  Ticker: ORX Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 705,900,000
(Year Ending Jan 2017).
Employees: 102
  Currency: Swedish Kronor Market Cap: 1,014,726,487
  Fiscal Yr Ends: December Shares Outstanding: 34,870,326
  Share Type: Aktie Closely Held Shares: 4,255,753
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.